Could a single protein unlock the secrets of colorectal cancer?

NCT ID NCT07778628

Completed Knowledge-focused Sponsor: Sohag University Source: ClinicalTrials.gov ↗

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This study investigates whether a protein called WT1 is present in colorectal cancer tissue and whether its presence relates to tumor characteristics like grade, spread, and invasion. Researchers will analyze tissue samples from 60 patients with colorectal adenocarcinoma using a special staining technique. The goal is to see if WT1 could serve as a useful marker for understanding this cancer better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: immunohistochemical staining with WT1 antibody
What this could lead to: If WT1 is found in colorectal cancer, it could become a marker for tumor aggressiveness or a target for future therapies.
What could go wrong: This is a small, early study that only looks at tissue samples. Finding WT1 does not guarantee it will be useful for treatment or diagnosis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colonic neoplasm colorectal adenocarcinoma colorectal cancer colorectal neoplasm Wilms tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLORECTAL CANCER

Contacts and locations

Locations

Faculty of Medicine, Sohag University

Sohag, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.